238 related articles for article (PubMed ID: 16254349)
1. A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity.
Faber M; Faber ML; Papaneri A; Bette M; Weihe E; Dietzschold B; Schnell MJ
J Virol; 2005 Nov; 79(22):14141-8. PubMed ID: 16254349
[TBL] [Abstract][Full Text] [Related]
2. Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein.
Mebatsion T
J Virol; 2001 Dec; 75(23):11496-502. PubMed ID: 11689631
[TBL] [Abstract][Full Text] [Related]
3. In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife.
Dietzschold ML; Faber M; Mattis JA; Pak KY; Schnell MJ; Dietzschold B
Vaccine; 2004 Dec; 23(4):518-24. PubMed ID: 15530701
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein-mediated induction of apoptosis limits the spread of attenuated rabies viruses in the central nervous system of mice.
Sarmento L; Li XQ; Howerth E; Jackson AC; Fu ZF
J Neurovirol; 2005 Dec; 11(6):571-81. PubMed ID: 16338751
[TBL] [Abstract][Full Text] [Related]
5. A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein.
Takayama-Ito M; Inoue K; Shoji Y; Inoue S; Iijima T; Sakai T; Kurane I; Morimoto K
Virus Res; 2006 Aug; 119(2):208-15. PubMed ID: 16473429
[TBL] [Abstract][Full Text] [Related]
6. Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus.
Faber M; Faber ML; Li J; Preuss MA; Schnell MJ; Dietzschold B
J Virol; 2007 Jul; 81(13):7041-7. PubMed ID: 17459937
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.
Faber M; Pulmanausahakul R; Hodawadekar SS; Spitsin S; McGettigan JP; Schnell MJ; Dietzschold B
J Virol; 2002 Apr; 76(7):3374-81. PubMed ID: 11884563
[TBL] [Abstract][Full Text] [Related]
8. Amino acid substitutions at positions 242, 255 and 268 in rabies virus glycoprotein affect spread of viral infection.
Ito Y; Ito N; Saito S; Masatani T; Nakagawa K; Atoji Y; Sugiyama M
Microbiol Immunol; 2010 Feb; 54(2):89-97. PubMed ID: 20377742
[TBL] [Abstract][Full Text] [Related]
9. Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic.
McGettigan JP; Pomerantz RJ; Siler CA; McKenna PM; Foley HD; Dietzschold B; Schnell MJ
J Virol; 2003 Jan; 77(1):237-44. PubMed ID: 12477829
[TBL] [Abstract][Full Text] [Related]
10. Multiple amino acids in the glycoprotein of rabies virus are responsible for pathogenicity in adult mice.
Takayama-Ito M; Ito N; Yamada K; Sugiyama M; Minamoto N
Virus Res; 2006 Feb; 115(2):169-75. PubMed ID: 16188341
[TBL] [Abstract][Full Text] [Related]
11. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.
Foley HD; McGettigan JP; Siler CA; Dietzschold B; Schnell MJ
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14680-5. PubMed ID: 11114165
[TBL] [Abstract][Full Text] [Related]
12. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
[TBL] [Abstract][Full Text] [Related]
13. Efficient N-glycosylation at position 37, but not at position 146, in the street rabies virus glycoprotein reduces pathogenicity.
Yamada K; Noguchi K; Nishizono A
Virus Res; 2014 Jan; 179():169-76. PubMed ID: 24177272
[TBL] [Abstract][Full Text] [Related]
14. Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV.
Wirblich C; Schnell MJ
J Virol; 2011 Jan; 85(2):697-704. PubMed ID: 21068252
[TBL] [Abstract][Full Text] [Related]
15. Characterization of street rabies virus variants with an additional N-glycan at position 247 in the glycoprotein.
Yamada K; Noguchi K; Nishizono A
Arch Virol; 2014 Feb; 159(2):207-16. PubMed ID: 23921623
[TBL] [Abstract][Full Text] [Related]
16. Addition of a single N-glycan to street rabies virus glycoprotein enhances virus production.
Yamada K; Noguchi K; Nonaka D; Morita M; Yasuda A; Kawazato H; Nishizono A
J Gen Virol; 2013 Feb; 94(Pt 2):270-275. PubMed ID: 23114627
[TBL] [Abstract][Full Text] [Related]
17. Regulation of N-linked core glycosylation: use of a site-directed mutagenesis approach to identify Asn-Xaa-Ser/Thr sequons that are poor oligosaccharide acceptors.
Kasturi L; Chen H; Shakin-Eshleman SH
Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):415-9. PubMed ID: 9163332
[TBL] [Abstract][Full Text] [Related]
18. A unique substitution at position 333 on the glycoprotein of rabies virus street strains isolated from non-hematophagous bats in Brazil.
Sato G; Kobayashi Y; Motizuki N; Hirano S; Itou T; Cunha EM; Ito FH; Sakai T
Virus Genes; 2009 Feb; 38(1):74-9. PubMed ID: 18941881
[TBL] [Abstract][Full Text] [Related]
19. Studies on the conditions required for structural and functional maturation of rabies virus glycoprotein (G) in G cDNA-transfected cells.
Sakai M; Kankanamge PJ; Shoji J; Kawata S; Tochikura TS; Kawai A
Microbiol Immunol; 2004; 48(11):853-64. PubMed ID: 15557743
[TBL] [Abstract][Full Text] [Related]
20. Serial passage of a street rabies virus in mouse neuroblastoma cells resulted in attenuation: potential role of the additional N-glycosylation of a viral glycoprotein in the reduced pathogenicity of street rabies virus.
Yamada K; Park CH; Noguchi K; Kojima D; Kubo T; Komiya N; Matsumoto T; Mitui MT; Ahmed K; Morimoto K; Inoue S; Nishizono A
Virus Res; 2012 Apr; 165(1):34-45. PubMed ID: 22248643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
